These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 3526155

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
    Flaherty JP, Waitley D, Edlin B, George D, Arnow P, O'Keefe P, Weinstein RA.
    Am J Med; 1989 Nov 30; 87(5A):278S-282S. PubMed ID: 2686429
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
    Anaissie EJ, Fainstein V, Bodey GP, Rolston K, Elting L, Kantarjian H, Cabanillas F, McCredie KB.
    Am J Med; 1988 Mar 30; 84(3 Pt 2):581-9. PubMed ID: 3279774
    [Abstract] [Full Text] [Related]

  • 8. Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients.
    Verhagen CS, de Pauw B, de Witte T, Janssen J, Williams K, de Mulder P, Bothof T.
    Antimicrob Agents Chemother; 1987 Feb 30; 31(2):191-6. PubMed ID: 3551829
    [Abstract] [Full Text] [Related]

  • 9. Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patients.
    Kramer BS, Ramphal R, Rand KH.
    Antimicrob Agents Chemother; 1986 Jul 30; 30(1):64-8. PubMed ID: 3530126
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Granulocytopenia in hospitalized patients. II. A prospective comparison of two antibiotic regimens in the empiric therapy of febrile patients.
    Gurwith M, Brunton JL, Lank B, Ronald AR, Harding GK, McCullough DW.
    Am J Med; 1978 Jan 30; 64(1):127-32. PubMed ID: 623129
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
    Marie JP, Marjanovic Z, Vekhoff A, Bouvet A, Chast F, Levy V, Baudard M, Legrand O, Rio B, Delmer A, Zittoun R.
    Support Care Cancer; 1999 Mar 30; 7(2):89-94. PubMed ID: 10089089
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A study of antibiotic therapy in fever of unknown origin in neutropenic cancer patients.
    Björnsson S, Preisler H, Henderson ES.
    Med Pediatr Oncol; 1977 Mar 30; 3(4):379-85. PubMed ID: 337094
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S, Raccah R, Santilli S, Micozzi A, Girmena C, Martino P, Avvisati G.
    Chemioterapia; 1988 Oct 30; 7(5):323-6. PubMed ID: 3066517
    [Abstract] [Full Text] [Related]

  • 18. [Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
    Marie JP, Pico JL, Chiche D, Fitoussi F, Delmer A, Baume D, Rio B, Ajchenbaum F, Richet H, Tancrède C.
    Presse Med; 1988 Oct 26; 17(37):1968-70. PubMed ID: 2973598
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.